NCT03353012

Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Chulalongkorn University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant.

Detailed description

* To study and compare acceptability and tolerance between breast-feeding post-partum woman, who receive contraceptive implant 48-72 hours after giving birth or at 5-7 weeks after giving birth, using either Levonorgestrel or Etonogestrel contraceptive implant. * Participants who wish to attend the study will be invited to choose between Levonorgestrel and Etonogestrel contraceptive implant, then they will be randomized into immediate postpartum or delay postpartum group. They will be follow-up at 6 and 12 weeks after receive contraceptive implant. * Information about side effects, breastfeeding status, child growth, acceptability and tolerance will be noted using medical records and interviewing, gathering on paper case record forms. * Sample size N = 60 (30 in each group (Immediate and delay postpartum group, 15 in each subgroup (Levonogestrel and Etonogestrel group)) This number of sample size is already counted with 10% data loss

Conditions

• Breastfeeding
• Post Partum

Interventions

Type	Name	Description
DRUG	Etonogestrel Drug Implant	Etonogestrel 68 mg (single rod) is implanted at inner arm of participant.
DRUG	Levonorgestrel Drug Implant	Levonorgestrel 75 mg (2 rods) are implanted at inner arm of participant.

Timeline

• Start date: 2018-01-01
• Primary completion: 2018-05-01
• Completion: 2018-08-01
• First posted: 2017-11-24
• Last updated: 2019-07-26

Locations

1 site across 1 country: Thailand